Powered by

Odyssey shakes hands on $500m-plus deal for Linden’s ProPharma

Sep 22, 2020 - peHUB
Mergers and Acquisitions

Odyssey Investment Partners is buying ProPharma Group from Linden Capital Partners in a deal valuing the compliance-related pharma services company north of $500 million, according to people familiar with the matter. 

ProPharma’s existing management team, including CEO Dawn Sherman, will continue to run the company, investing in the deal alongside Odyssey.

The deal provides an exit for Chicago-based healthcare specialist Linden, whose investment in the company dates to Octo...